Inés Hernanz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Inés Hernanz has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Aina Moll-Udina
Ocular Inflammation and Infection Section, Department of Ophthalmology, Hospital Clínic de Barcelona
2 shared publications - Maite Sainz de la Maza
University of Barcelona
2 shared publications - Victor Llorenç
Hospital Clínic de Barcelona
2 shared publications - Alex Fonollosa
Department of Ophthalmology, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain
1 shared publication Alfredo Adan
Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain
1 shared publication- Alfredo Adán
Department of Ophthalmology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain
1 shared publication
Latest Publications
- 28 May 2026
- Published by Springer Nature in Clinical Rheumatology
- Vol. 45 (8) , 5123-5124
Multiple choroidal lesions, lymphadenopathy and pulmonary infiltrates: ocular involvement as first manifestation of sarcoidosis
- 28 May 2026
- Published by Springer Nature in Clinical Rheumatology
- Vol. 45 (8) , 5123-5124
Multiple choroidal lesions, lymphadenopathy and pulmonary infiltrates: ocular involvement as first manifestation of sarcoidosis
- 19 November 2021
- Published by BMJ in British Journal of Ophthalmology
- Vol. 107 (4) , 495-499
Presumed tuberculosis-related scleritis
Aims To evaluate the clinical characteristics and therapeutic outcome of patients with recurrent scleritis of unknown demonstrable aetiology and positive QuantiFERON-TB Gold In-Tube test (QFT). Methods Retrospective chart review of the demographic, clinical, laboratory and therapeutic outcome data of 15 patients. Clinical characteristics as well as remission rate after standard antituberculous therapy (ATT) were assessed. Results There were 9 men and 6 women with a mean age of 48.9 years (range, 32–73). Scleritis was diffuse in 10 patients (66.6%) and nodular in 5 patients (33.3%), 1 of them with concomitant posterior scleritis. It was bilateral in 7 patients (46.6%) and recurrent in all of them. Scleritis appeared after prior uveitis (10 patients, 66.6%) and/or with concomitant uveitis (5 patients, 33.3%) or peripheral keratitis (5 patients, 33.3%). Previous ocular surgery was found in 7 patients (46.6%). Previous extraocular tuberculosis (TB) infection or previous TB contact was detected in 11 patients (73.3%). No radiologic findings of active extraocular TB were detected. ATT was used in 15 patients, sometimes with the addition of systemic corticosteroids (5 patients) and methotrexate (1 patient); 14 patients achieved complete remission (93.3%). Conclusion Presumed TB-related scleritis may appear in recurrent scleritis of unknown origin and positive QFT. It may occur after prior uveitis and/or concomitantly with uveitis or peripheral keratitis, and it may be triggered by previous ocular surgery. No patients had evidence of concurrent active extraocular infection, although many had previous TB infection or TB contact. ATT was effective, sometimes with the addition of systemic corticosteroids and methotrexate.
- 19 November 2021
- Published by BMJ in British Journal of Ophthalmology
- Vol. 107 (4) , 495-499
Presumed tuberculosis-related scleritis
Aims To evaluate the clinical characteristics and therapeutic outcome of patients with recurrent scleritis of unknown demonstrable aetiology and positive QuantiFERON-TB Gold In-Tube test (QFT). Methods Retrospective chart review of the demographic, clinical, laboratory and therapeutic outcome data of 15 patients. Clinical characteristics as well as remission rate after standard antituberculous therapy (ATT) were assessed. Results There were 9 men and 6 women with a mean age of 48.9 years (range, 32–73). Scleritis was diffuse in 10 patients (66.6%) and nodular in 5 patients (33.3%), 1 of them with concomitant posterior scleritis. It was bilateral in 7 patients (46.6%) and recurrent in all of them. Scleritis appeared after prior uveitis (10 patients, 66.6%) and/or with concomitant uveitis (5 patients, 33.3%) or peripheral keratitis (5 patients, 33.3%). Previous ocular surgery was found in 7 patients (46.6%). Previous extraocular tuberculosis (TB) infection or previous TB contact was detected in 11 patients (73.3%). No radiologic findings of active extraocular TB were detected. ATT was used in 15 patients, sometimes with the addition of systemic corticosteroids (5 patients) and methotrexate (1 patient); 14 patients achieved complete remission (93.3%). Conclusion Presumed TB-related scleritis may appear in recurrent scleritis of unknown origin and positive QFT. It may occur after prior uveitis and/or concomitantly with uveitis or peripheral keratitis, and it may be triggered by previous ocular surgery. No patients had evidence of concurrent active extraocular infection, although many had previous TB infection or TB contact. ATT was effective, sometimes with the addition of systemic corticosteroids and methotrexate.
- 13 July 2020
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 29 (7-8) , 1591-1598
Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy
To assess the efficacy and safety of adalimumab in elderly patients with noninfectious uveitis (NIU). An observational, retrospective, multicenter study was done. Changes in best-corrected visual a...
- 13 July 2020
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 29 (7-8) , 1591-1598
Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy
To assess the efficacy and safety of adalimumab in elderly patients with noninfectious uveitis (NIU). An observational, retrospective, multicenter study was done. Changes in best-corrected visual a...